South32 logo

S32 - South32 News Story

A$2.85 0.0  0.0%

Last Trade - 7:10am

Basic Materials
Large Cap
Market Cap £7.52bn
Enterprise Value £7.32bn
Revenue £4.16bn
Position in Universe 43rd / 1902

South32 Limited - Daily Share Buy-Back Notice

Thu 4th March, 2021 8:54am
RNS Number : 1702R
South32 Limited
04 March 2021

04 March 2021


South32 Limited

(Incorporated in Australia under the Corporations Act 2001 (Cth))

(ACN 093 732 597)

ASX / LSE / JSE Share Code: S32 ADR: SOUHY

ISIN:  AU000000S320


South32 Limited




The Daily share buy-back notice (Appendix 3E) lodged on the Australian Securities Exchange and voluntarily disclosed on the Johannesburg Stock Exchange and London Stock Exchange has today been submitted to the National Storage Mechanism and will shortly be available for inspection at


·      South32 Limited - Daily share buy-back notice

Further information on South32 can be found at: 



Alex Volante

T     +61 8 9324 9029

M    +61 403 328 408


Tom Gallop

T    +61 8 9324 9030

M   +61 439 353 948





Rebecca Keenan
+61 8 9324 9364

M   +61 402 087 055


Jenny White

T    +44 20 7798 1773

M   +44 7900 046 758



JSE Sponsor: UBS South Africa (Pty) Ltd
04 March 2021


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.